Study: Septic shock drug shortage associated with higher mortality in 2011

Mar 22, 2017 - 03:28 PM

The U.S. norepinephrine shortage in 2011 was associated with increased mortality among hospital patients with septic shock, according to a study published online yesterday by the Journal of the American Medical Association. The Food and Drug Administration reported a severe nationwide shortage of norepinephrine in 2011 due to production interruptions at three drug manufacturers. The study found that septic shock patients at hospitals experiencing a norepinephrine shortage had a 3.7% higher rate of in-hospital mortality, based on a retrospective analysis of administrative and pharmacy billing data from the Premier Healthcare Database. The Food and Drug Administration Safety and Innovation Act of 2012 included a number of AHA-supported provisions to help alleviate critical drug shortages.

Related News Articles

Headline
FDA, Baxter issue update on manufacturing recovery in Puerto Rico
The Food and Drug Administration and Baxter provided an update on efforts Baxter and other companies have taken to reduce the risk of shortages of…
Headline
FDA approves drug imports, CMS certain blanket waivers after hurricanes
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
FDA acts to prevent shortages of drugs made in Puerto Rico
In the wake of Hurricane Maria, the Food and Drug Administration is working to avoid critical shortages of drugs made in Puerto Rico, which is home to dozens…
Headline
FDA: Hospira recalls emergency syringe drugs due to potential lack of sterility
Hospira, a Pfizer company, has voluntarily recalled certain lots of 8.4% sodium bicarbonate injection and other emergency syringe drugs distributed since…
Headline
HHS webinar June 8 on injectable drug shortages, coping strategies
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will host a June 8 webinar on strategies to…
Headline
FDA approves temporary import of sodium bicarbonate injection due to shortage
The Food and Drug Administration recently authorized the temporary import of a sodium bicarbonate injection product from Australia to address a critical…